Introduction
Extraocular muscles (EOMs) comprise a group of highly specialized skeletal muscles controlling eye movements (Demer, 2007) . The EOMs represent a unique skeletal muscle phenotype based on a range of properties, including specialized patterns of innervation and diversity of expressed sarcomeric myosin isoforms (Spencer and Porter, 2006) . The developmental origin of EOMs adds another distinct facet to this muscle group. While body and limb muscles develop from the somites, EOMs are descended from prechordal and paraxial head mesoderm (Couly et al., 1992; Noden and Francis-West, 2006) . Accordingly, the progenitors establishing the EOM primordia are of Pax3-negative origin, in contrast to the Pax3-positive lineage origin of limb and body muscles (Goulding et al., 1994; Horst et al., 2006; Tajbakhsh et al., 1997) . Nevertheless, EOM development is orchestrated by the same members of the bHLH transcription factor family (MyoD, Myf5, MRF4, myogenin) that are involved in the specification and differentiation of body and limb muscles (Kassar-Duchossoy et al., 2004; Noden and Francis-West, 2006; Sambasivan et al., 2009) .
The EOMs are also distinct from other skeletal muscles in their differential response to disease, being preferentially involved or spared in a variety of metabolic, mitochondrial and neuromuscular disorders (Kaminski et al., 2002; Schoser and Pongratz, 2006; Valdez et al., 2012; Yu Wai Man et al., 2005) . Especially intriguing for muscular dystrophy research is the sparing of this muscle group in Duchenne muscular dystrophy. EOMs remain anatomically and functionally spared even at the late stages of the disease despite the severe pathology observed in other skeletal muscles (Kaminski et al., 1992; Khurana et al., 1995) . Likewise, EOMs are Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/developmentalbiology spared in animal models of muscular dystrophy resulting from the absence of dystrophin or other dystroglycan complex-related proteins (Khurana et al., 1995; Porter and Karathanasis, 1998; Porter et al., 2001) . The mechanism behind EOM sparing has remained unclear (Pacheco-Pinedo et al., 2009; Porter, 1998; Zeiger et al., 2010) , but specific properties of EOM myogenic progenitors have been proposed as possible contributory factors (Kallestad et al., 2011; Porter et al., 2006) .
Satellite cells (SCs), Pax7 þ myogenic progenitors situated between the basal lamina and sarcolemma of the myofibers, have long been recognized as the major source of myonuclei during muscle growth and repair (Mauro, 1961; Seale et al., 2000; Yablonka-Reuveni, 2011) . SCs are proliferative during the postnatal growth phase, adding nuclei to the enlarging myofibers (Moss and Leblond, 1971; White et al., 2010) . In adult muscles, SCs are typically quiescent, but can be activated in response to muscle injury (Montarras et al., 2013; Schultz et al., 1978) . Depending on the magnitude of tissue trauma, SCs may divide minimally to repair subtle damage within individual myofibers or produce a larger progeny pool that forms new myofibers in cases of overt muscle trauma (Grounds and Yablonka-Reuveni, 1993; Hawke and Garry, 2001 ). In addition to generating differentiated myogenic progeny, at least some SCs can self-renew, thereby meeting the defining criteria of bona fide resident stem cells (Collins et al., 2005; Kuang et al., 2007; Sacco et al., 2008) . Most SC studies, whether performed in vivo or with isolated cells, have focused on the easily accessible limb muscles. Such studies have provided significant insights into SC molecular/ cellular signatures during growth, aging and repair (Chang and Rudnicki, 2014; Zammit et al., 2006) . Limb muscles have also been the main focus in studies on the potential of SCs as donor cells to alleviate muscle wasting, especially in dystrophinopathy. Despite their myogenic aptitude, enthusiasm for using limb SC-derived myoblasts has been weakened by their limited expandability and engraftment outcomes (Konieczny et al., 2013; Miller et al., 1997; Tremblay et al., 1993; Wilschut et al., 2012) . This drawback may be related to heterogeneity in limb SC "stemness" with only a minority of cells appearing capable of both progeny production and self-renewal (Day et al., 2010; Kuang et al., 2007) . Indeed, in mouse transplantation studies only a very small fraction of donor SCs was able to contribute to myofiber formation and to enter the satellite cell niche within the host muscle (Beauchamp et al., 1999; Collins et al., 2005; Sacco et al., 2008) . Subsequently, alternative (non-SC) sources of donor cells for muscle therapy have been explored (Negroni et al., 2011; Tedesco and Cossu, 2012) , while bona fide SCs from non-limb muscle groups have received only limited attention. Significantly, insight into SCs in muscle groups that are spared from the impact of Duchenne muscular dystrophy could unveil new cellular and molecular players that may be beneficial for treating muscle wasting disorders.
Although the unique anatomical and physiological features of EOMs have drawn much interest (Andrade et al., 2000; da Silva Costa et al., 2012; Spencer and Porter, 2006; Zhou et al., 2010) , knowledge about the EOM myogenic progenitors is currently limited. One study that has used transgenic Pax7-nGFP mice for isolating and characterizing myogenic progenitors, placed the Pax7 þ SCs as the main myogenic population in adult EOM as in the other muscles (Sambasivan et al., 2009) . Additionally, the isolation of a number of EOM populations (SP, MP, EECD34) containing myogenic cells has been described (Kallestad et al., 2011; Kallestad and McLoon, 2010; McDonald et al., 2014) . Our interest in EOM SCs originated from an earlier study where we established EOM-derived myogenic cultures as a control for analysis of the myogenic potential of retina pericytes (Kirillova et al., 2007) . Using our standard approach for isolating myogenic cells (Danoviz and Yablonka-Reuveni, 2012) , we observed that EOM cultures produced numerous myogenic progeny despite the very small initial number of cells obtained from these tiny muscles (unpublished).
In the current study we aimed to specifically characterize EOM SCs and their regenerative capacity. We focus on their in-situ signature, in-vitro expansion, and in-vivo engraftment aptitude. To identify potential unique properties of EOM SCs, most aspects were analyzed in comparison to SCs from the limb and diaphragm somite-derived muscles.
Materials and methods

Mice
All mice were on C57BL/6 background and from colonies we have maintained long-term at the University of Washington. Mice were housed in a pathogen-free facility under 12:12-h light/dark cycle and were fed ad libitum Lab Diet 5053 (Purina Mills). Animal care and experimental procedures were approved by the Institutional Animal Care and Use Committee at the University of Washington. Most studies were performed with adult mice (4-6 month old) but as indicated in the Results, some studies were done with younger (3-week old) or older (12-24 month old) mice, and unless otherwise noted, only males were used. The following strains (all described in our previous studies) were used for tissue and cell isolation: (i) Knockin (Muzumdar et al., 2007) ] to generate F1 animals (Stuelsatz et al., 2012; Stuelsatz et al., 2014) . (ii) Transgenic, heterozygous Nestin-GFP (Mignone et al., 2004) and MLC3F-nLacZ [MLC3F¼muscle-specific myosin light chain 3F; AKA 3F-nlacZ-2E and Tg(Myl1-lacZ) 1Ibdml/J, (Beauchamp et al., 2000; Kelly et al., 1995) ]. (iii) Myf5 nLacZ , knockin heterozygous (Tajbakhsh et al., 1996; Tajbakhsh et al., 1997) . When indicated, reporter mice were crossed to generate double heterozygous Nestin-GFP/MLC3F-nLacZ and Nestin-GFP/ Myf5 nLacZ (Day et al., 2010) . (iv) Dystrophin-null mdx 4cv (Chapman et al., 1989; Im et al., 1996) were crossed with Nestin-GFP mice to produce mdx 4cv /Nestin-GFP experimental mice. Additionally, Rag1
À / À /mdx 5cv double-null mice (8-9 week old)
were used as hosts in cell transplantation studies. This dystrophinnull strain that also lacks mature T and B cells (Mombaerts et al., 1992) was initially developed at the Jackson Lab for studies of Dr. Emanuela Gussoni (Boston Children's Hospital, unpublished) . Notably, the mdx 4cv and mdx 5cv alleles were generated by point mutations upon mutagen-treatment of male mice (Banks et al., 2010; Chapman et al., 1989; Im et al., 1996) . These mdx "cv" strains have been preferred by some laboratories due to the reduced occurrence of revertants (i.e., spontaneously appearing dystrophin þ myofibers, Lu et al., 2000) compared to the "standard" mdx mice (spontaneous mutation) (Arpke et al., 2013; Danko et al., 1992; Decrouy et al., 1997; Im et al., 1996; Judge et al., 2006) .
Tissue harvesting
Hindlimb muscles (LIMB; consisting of tibialis anterior [TA], extensor digitorum longus [EDL] and gastrocnemius) and whole diaphragm (DIA; includes the costal and crural muscles and the central tendon) were harvested according to our routine procedures for cell isolation or tissue sectioning (Danoviz and YablonkaReuveni, 2012; Day et al., 2007; Stuelsatz et al., 2012) . For the EOM we processed two types of preparations, one for tissue sections and one for cell isolation as detailed in our recent publication (Stuelsatz et al., 2014) . A typical EOM preparation for histology comprised the EOMs, the retractor bulbi muscle (an ocular accessory muscle involved in retracting the eye into the orbit forcing the mouse third eyelid across the cornea), the optic nerve and the associated periocular connective tissues, all attached to the eyeball (LifeMap, 2013) , while for cell isolation only the EOMs were collected. In both types of EOM preparations, all 4 rectus muscles were included in their entirety, but the 2 oblique muscles typically tear during isolation (due to their association with the trochlea or the orbit wall), resulting in loss of a portion of these muscles. Tissues harvested for histology or cell culture were kept at room temperature in PBS or DMEM solution, respectively, for subsequent processing. The DMEM solution consists of Dulbecco's modified Eagle's medium (high glucose, with L-glutamine, 110 mg/l sodium pyruvate, and pyridoxine hydrochloride, Hyclone) supplemented with antibiotics (50 U/ml penicillin and 50 mg/ml streptomycin, Gibco-Invitrogen) and was used throughout the various procedures described below.
Cell isolation
For each preparation, cells were typically isolated from 2-3 mice. Harvested tissues were dissociated according to our two established methods that rely either on Pronase digestion (Danoviz and YablonkaReuveni, 2012; or collagenase/dispase digestion (Ieronimakis et al., 2010; Stuelsatz et al., 2014) . When digested with Pronase, the isolated muscles were thoroughly cleaned while gently tearing the muscles apart into small pieces with forceps. Tissue digestion was then carried out for 1 h at 37 1C (with gentle swirling every 15 min) followed by vigorous trituration to release cells from the muscle bulk. When digested with collagenase/dispase, the isolated muscles were superficially cleaned from fascia and associated connective tissue, then cut into small pieces using scissors and digested for 45 min at 37 1C with intermittent triturations every 15 min. For both tissue digestion approaches, the isolated cell suspensions were filtered through cell strainers (100 mm and 40 mm) and cells were then harvested by centrifugation at 1000 Â g for 10 min.
Cell sorting by flow cytometry
Cell pellets obtained from digested muscles were suspended in DMEM containing 10% horse serum and 10 μM Hoechst 33342 and incubated for 30 min at 37 1C, after which preparations were kept on ice. From this point, two different protocols, detailed in our previous publications, were used to isolate SCs by flow cytometry (Day et al., 2007; Stuelsatz et al., 2014) . When working with Pronase-digested preparations from Nestin-GFP mice, the Hoechst-labeled cells were directly sorted based on GFP expression (Day et al., 2007) . For cell preparations harvested by collagenase/dispase, the Hoechst-labeled cells were pelleted, resuspended in a solution of fluorescent antibodies and incubated on ice for 1 h (Stuelsatz et al., 2014) . The antibody cocktail consisted of anti-Sca1 (APC, clone D7), anti-CD31 (APC, clone 390) and anti-CD45 (PE-Cy7, clone 30-F11), all from eBioscience, diluted in ice-cold PBS containing 0.3% bovine serum albumin (BSA, Omnipur, fractionV; Calbiochem) to a final concentration of 600 ng/10 6 cells for each antibody except for the anti-Sca1, used at 300 ng/10 6 cells (Stuelsatz et al., 2014) . The cells were then rinsed with and resuspended in ice-cold PBS-0.3%BSA before sorting. This second approach that relies on collagenase/dispase digestion and sorting based on both Nestin-GFP and cell surface antigen, allows measuring CD45 þ cells when desired (see Results). Additionally, removal of endothelial cells (CD31 þ ), which also express the Nestin-GFP transgene (Day et al., 2007) , is achieved by the triple antigen CD31/CD45/Sca1 negative selection, in agreement with the published signature of LIMB SCs (Ieronimakis et al., 2010; Sacco et al., 2008) . Differently, our Pronase-based protocol used for muscle dissociation, minimizes the contribution of non-myogenic cells even without cell sorting (Danoviz and Yablonka-Reuveni, 2012; Shefer et al., 2006) , yielding pure myogenic cultures from the Nestin-GFP high sorted populations (Day et al., 2007 ). An Influx Cell Sorter (BD Biosciences, equipped with 350, 488 and 638 nm lasers) was used and sorted cells were collected within the G0-G1 population defined based on Hoechst staining, thereby eliminating residual cell aggregates and cellular debris. In some experiments, we also labeled the cells with 7-aminoactinomycin D (7AAD, 1:200; Invitrogen, added just before sorting) for dead cell exclusion. The 7AAD analyses demonstrated that our sorted cell fractions of interest were free of dead cells; hence, selecting for G0-G1 cells based on Hoechst dye was sufficient. Sort gates were determined by comparing fluorophore signal intensities between the unstained control and each single antibody/ fluorophore control. Positive events were set to at least 10 times the fluorescence intensity of negative events. Data was acquired at 20,000-100,000 events per sample and sorted cells were collected in standard growth medium. Post-hoc analysis and flow cytometry plots were generated using FlowJo (TreeStar).
Analysis of sorted cells in primary culture and clonal assays
Growth medium consisted of DMEM containing 20% fetal bovine serum (FBS, Gibco-Invitrogen), 10% horse serum (HS, Gibco-Invitrogen), and 1% chicken embryo extract prepared from whole 10-day-old embryos (Shefer and Yablonka-Reuveni, 2005 ). This growth medium supports both proliferation and differentiation of cultured SCs (Shefer et al., 2006; . Tissue culture wells were coated with Matrigel diluted in DMEM (1 mg/ml final concentration, BD Biosciences) (Danoviz and Yablonka-Reuveni, 2012) . Cultures were incubated at 37 1C, 5% CO 2 in a humidified tissue culture incubator and growth medium and was replaced every third day after initial plating.
Primary cultures were initiated in 24-well trays at a density of 1000 cells per well. For each preparation (per each muscle group) 3-5 wells were typically seeded for analyses. Depending on overall cell density at the time point of interest, 10-25 arbitrary fields were quantified per well using a 20 Â objective. Quantifications were based on counting DAPI-stained cell nuclei (and when applicable immunolabeled cells as described later).
Clones were established in 48-well trays using a seeding density of 4 cells per well for LIMB and 2 cells per well for DIA and EOM preparations. This clonal plating density was based on our pilot studies that indicated a lower clonal recovery of LIMB SCs. Following our earlier studies (Day et al., 2010; Shefer et al., 2004) , clonal cultures were left undisturbed during the initial 4 days, then individual colonies were identified and their positions were marked to facilitate monitoring progress of each clone at later time points. Cultures were maintained for up to 3 weeks to monitor growth, formation of myotubes, and the emergence of Nestin-GFP positive cells. Clone size was determined at day 10 by counting the number of DAPI-stained nuclei in fixed cultures. For each clone, a manual cell counting of individual nuclei (in single cells and myotubes) was performed using ImageJ software after merging in Photoshop all low magnification images (taken with 4 Â objective). Alternatively, clone size was estimated according to the size of the microscopic field the clone occupied on days 7 and 21 (i.e. clones were categorized as small, medium, large or X-large depending on whether the clone occupied a 20 Â , 10 Â , 4 Â or several 4 Â objective fields, respectively).
Immunofluorescence analysis of freshly isolated cells, cultured cells, and single myofibers
All of preparations were fixed with paraformaldehyde (PFA, 2% final concentration) for 10 min at room temperature, then permeabilized with Triton X-100, blocked with normal goat serum, immunolabeled, DAPI stained and mounted with Vectashield, all according to our established protocols (Danoviz and Yablonka-Reuveni, 2012; Shefer et al., 2006) . Freshly isolated cells were obtained from Pronase digested muscles following the method described above (except that here, muscles did not require to be as thoroughly cleaned from connective tissues) and pellets were resuspended in 150 μl of PBS and then deposited onto a Superfrost Plus slides (Thermo Fisher Scientific) by cytocentrifugation (1000 rpm for 5 min, Wescor cytopro cytocentrifuge). Notably, the use of cell preparations that were not subjected to cell sorting allowed for a higher cell number yield, achieving optimal pelleting during cytocentrifugation. Cultured cells were prepared by Pronase or collagenase/dispase digestion of the muscles as described above. EOM myofibers were isolated according to our protocol (Keire et al., 2013, Note 18d) and further processed as in our EDL myofiber preparations (Keire et al., 2013; Shefer et al., 2006) .
The following primary antibodies were used: anti-Pax7 (mouse IgG1, 1:100, bioreactor supernatant, Developmental Studies Hybridoma Bank [DSHB]); anti-sarcomeric myosin heavy chain (mouse IgG2b, clone MF20, hybridoma supernatant, DSHB, 1:2); anti-Ki67 (rabbit IgG, 1:300, Abcam, ab66155). Secondary antibodies used were all produced in goat and conjugated with AlexaFluor (Invitrogen, 1:1000 dilution); these included anti-mouse IgG1-568; antimouse IgG2b-647; anti-rabbit IgG-568. GFP reporter detection in preparations from Nestin-GFP mice was typically done based on direct fluorescence, alternatively, as the fixation for immunostaning can reduce the intensity of direct GFP fluorescence, an anti-GFP antibody was used if necessary for signal amplification (rabbit IgG, 1:20,000 Abcam, ab6556, Day et al., 2010) .
Analysis of tissue sections (immunofluorescence, H&E staining)
Freshly harvested tissues were embedded in OCT (Tissue-Tek), flash frozen in isopentane cooled with liquid nitrogen and stored at À 80 1C until ready to be cut into 10-μm thick transverse sections using a Leica CM1850 cryostat. Sections were placed on Superfrost Plus slides and allowed to air dry for about 30 min before being processed immediately or stored at À 80 1C.
For Pax7/laminin double immunostaining, sections were fixed for 10 min in 2% PFA and antigen retrieval (required for optimal Pax7 detection) was performed by incubating slides in a solution consisting of 10 mM Tris (pH 9), 1 mM EDTA, 0.05% Tween 20 for 30 min at 97 1C and cooling slides in the same buffer at room temperature for 10 min (adapted from He et al., 2010) . Slides were removed from retrieval buffer, allowed to air dry briefly, rinsed in Tris buffered saline (TBS) for 5 min and allowed to air dry briefly again. Sections were then blocked overnight with normal goat serum, reacted with antibodies, counterstained with DAPI and mounted, all following our routine immunostaining protocol (Danoviz and Yablonka-Reuveni, 2012; Stuelsatz et al., 2014) . Primary antibodies included the anti-Pax7 detailed above and an antilaminin (1:100; rabbit IgG; ab2034, Chemicon/Millipore). Secondary antibodies were AlexaFluor-conjugated goat anti-rabbit IgG-568 and goat anti-mouse IgG2a-488 (1:1000; Invitrogen).
For hematoxylin and eosin (H&E) staining, sections of unfixed tissues were hydrated in water for 5 min and then stained in Harris hematoxylin for 3-5 min. Slides were then rinsed in tap water, dipped in Scott's bluing reagent, rinsed in tap water, incubated in 70% ethanol for 2 min, stained in eosin Y (0.25% solution) for 2 min, dehydrated through graded alcohols and cleared in Xylene substitute before being mounted with Xylene substitute mounting medium (Thermo Fisher Scientific).
X-gal staining β-galactosidase (β-gal) activity in cells expressing lacZ reporter was detected by X-gal staining in cultured cells or whole TA muscles, as previously described (Day et al., 2010; Stuelsatz et al., 2012) . Cell cultures were fixed in 2% PFA for 10 min at room temperature as described above for cell culture immunostaining. When staining cells immediately after plating, the seeded cells were allowed to settle down for $ 30 min and then fixed as above. Whole TAs were cut longitudinally into 2 halves and then fixed in the same manner as the cell cultures, except that fixation was done for 15 min. Fixed specimens were incubated in X-gal staining solution for 4-6 h or overnight, for cultured cells or whole muscle, respectively.
SC transplantation to host TA muscles and engraftment analysis
, 8-9 week old) were anesthetized with isoflurane. Analgesic (ketoprofen) was then administrated subcutaneously (5 mg/kg) and the site of injection was shaved and prepped with ethanol and betadine. A small incision was made through the skin to expose the base of the TA from the distal tendon to mid-TA. The intramuscular injection was done with a Hamilton syringe equipped with a 31 G needle (0.85″ length, point style 4 at 121 bevel) entering in the lower end of the muscle and traveling to about 3/4 up before being slowly pulled back while releasing cells in order to disperse cells evenly along the needle path. For each host animal, the TA from one leg was injected with EOM donor SCs, while the TA from the contralateral leg was injected with LIMB donor SCs (15 μl per injection). Following cell injection the skin was closed with a surgical adhesive and a supplemental isotonic saline solution was administrated via intraperitoneal injection.
Donor SCs were isolated from Pronase-digested muscles of adult (4-5 month old) Nestin-GFP/MLC3F-nLacZ mice by GFPbased flow cytometry as described above. As the MLC3F-nLacZ transgene produces a specific LacZ expression in myofiber nuclei (Beauchamp et al., 2000; Day et al., 2010; Kirillova et al., 2007; Zammit et al., 2006) , it has been used to detect donor SC-derived differentiated progeny in engraftment studies (Collins et al., 2005) . Freshly sorted cells were collected in PBS and their concentration adjusted to 1000 cells per 15 μl and kept on ice until the injection.
Parallel aliquots were followed-up in primary culture conditions (as detailed above) for quality control of the injected preparations. Both males and females were used as host and donor mice but sexes were always matched between the donor and the corresponding host mouse.
Transplanted muscles were collected 21 days post-transplantation to evaluate engraftment by X-gal staining and genomic analysis of donor-derived cells based on levels of LacZ and GFP genes (detailed below). For both engraftment analysis approaches, controls with vehicle only injected TAs were also performed to ensure reliability of detection. For the genomic analysis, DNA from whole engrafted TA muscles was isolated using DNeasy kit (Qiagen) and used for analyzing by PCR the level of GFP and MLC3F-nLacZ genes (donor-derived) vs. H-ras and Cyp1A1 (contributed by both host and donor cells). PCR was performed using HotStarTaq DNA polymerase (Qiagen) in a 25 μl total volume using 10 pmol of forward and reverse primers and 2 μl or 4 μl of DNA (100 ng/μl stock solution) per reaction for GFP and LacZ or H-ras and Cyp1A1, respectively. The PCR program consisted of incubation at 95 1C for 10 min, followed by 28-32 cycles of 94 1C for 30 s, 62 1C for 45 s, 72 1C for 1 min, and a final extension step at 72 1C for 10 min. The number of amplification cycles was 28 for H-ras and Cyp1A1, and 32 for LacZ and GFP. PCR products were separated on 1.5% agarose gels containing 1:10,000 dilution of SYBR Green I (Molecular Probes). Gels were imaged using Gel Logic 212 Pro (Carestream). Quantification of the resulting bands for each PCR product was done using ImageJ software. Each donor gene product (LacZ and GFP) was first normalized with each of the reference gene product (Cyp1A1 and H-ras). The EOM/LIMB ratio was then calculated for each of these normalized values. Given that within the same mouse these ratios are comparable regardless of the donor or reference gene used, final results are presented per each mouse as the average of these ratios. Primer set sequences (and product size):
LacZ, GCTTCATCCACCACATACAG / CGATGAGCGTGGTGGTTATG (402 bp).
GFP, CGACGTAAACGGCCACAAG / GTAGTTGCCGTCGTCCTTG (259 bp).
H-ras, ATGACAGAATACAAGCTTGTGGTG / GGCAAATACACAGAG-GAAGCCCTC (459 bp, 249 bp if used for cDNA analysis) (Kastner et al., 2000; Smith et al., 1994) .
Cyp1A1, GACACAGTGATTGGCAGAGA / AACGGATCTATGGTCT-GACC (144 bp) (Dai et al., 2009 ).
Microscopy and imaging
Observations were made with an inverted fluorescent microscope (Eclipse TE2000-S, Nikon), except for TA engraftment studies by X-gal staining where a Nikon Stereoscopic Zoom Microscope (SMZ1500) was used. Images were typically acquired using CoolSNAP ES monochrome CCD camera (Photometrics) controlled with MetaVue Imaging System (Universal Imaging Corporation). For acquiring real color images of X-gal staining, images were taken with a Digital Sight DS-Ri1 color camera controlled by NIS-Elements F software (Nikon). Digitized images were assembled using Adobe Photoshop software.
Data analysis and statistics
Graphs were generated and data were analyzed by one-way ANOVA with Bonferroni-Holm or Tukey post-hoc analysis using Excel with Daniel's XL Toolbox Add-In (by Daniel Kraus, Würzburg, Germany). For all studies, unless otherwise noted, p-values of less than 0.05 were considered to be statistically significant and 3-5 experimental repeats were performed.
Results and discussion
Although derived from a Pax3-negative lineage, EOM myogenic progenitors display classic SC features in common with their limb and diaphragm counterparts
In accordance with EOM development from a Pax3-negative lineage (Harel et al., 2009; Sambasivan et al., 2009; Stuelsatz et al., 2014) , myogenic progenitors in adult EOMs do not demonstrate ancestral, nor current, expression of Pax3 (Fig. S1 ). Regardless of this distinct linage origin, in common with all muscles examined to date, myogenic progenitors in adult EOMs display classic SC features based on being of MyoD-positive lineage origin ( Fig. S1 ; in accordance with Kanisicak et al., 2009 ) and expressing Pax7 ( Fig. S2 ; as previously reported for postnatal (P10) EOM in Harel et al., 2009) . The presence of Pax7 þ SCs is evident in isolated EOM myofibers along with co-expression of the Nestin-GFP transgene (Fig. 1A) , previously reported by us as a characteristic of SCs in LIMB and DIA (Day et al., 2007; Day et al., 2010; Fig. S1 in Stuelsatz et al., 2012) . Pax7/Nestin-GFP co-expression was additionally established in freshly isolated SC preparations from EOM, LIMB and DIA (Fig. S2) . Also, in common with SCs in all muscle groups examined to date (Beauchamp et al., 2000; Day et al., 2010; Ono et al., 2010; Stuelsatz et al., 2012) , myogenic progenitors in adult EOM are β-gal positive when analyzed using the Myf5 nLacZ knockin reporter mouse (Fig. S3) . Next, we have extended our approach for SC isolation from LIMB and DIA SCs (Day et al., 2007; Day et al., 2010) , and utilized the Nestin-GFP transgene fluorescence to sort EOM SCs by flow cytometry (Figs. 1 and S3) . Antigen-based cell sorting further demonstrated that the bulk of EOM SCs (Nestin-GFP Fig. S3B and G-G″ 0 ), in agreement with the published signature of LIMB SCs (Ieronimakis et al., 2010; Sacco et al., 2008) . Our characterization of the sorted Nestin-GFP high cells according to myogenic marker expression (by immunostaining) in primary culture, shows a typical progression through proliferation, differentiation and renewal, as summarized schematically in Fig. 1C . During the initial days in culture (days 3-4), essentially all cells were positive for Pax7 and MyoD, a common signature of proliferating progeny of SCs (Halevy et al., 2004; Shefer et al., 2006; Zammit et al., 2004) , followed by the appearance of differentiating, Myogenin þ single cells, while formation of myotubes, that just had begun at day 6, was evident throughout the culture by day 7. EOM cultures were also monitored for the dynamics of Nestin-GFP transgene expression. As we have previously demonstrated for LIMB, SC proliferating progeny do not retain Nestin-GFP expression, but once cultures increase in cell density and develop myotubes, Nestin-GFP expression re-emerges in quiescent Pax7 þ /MyoD À cells (i.e. renewal cells) (Day et al., 2007; Day et al., 2010 (Day et al., 2007) . Notably, while the detection of renewal cells in SC cultures according to the emergence of Pax7 þ / MyoD À cells has been reported (Day et al., 2009; Halevy et al., 2004; Ono et al., 2010; Shefer et al., 2006; Zammit et al., 2004) , the expression of Nestin-GFP in renewal cells provides a visual means to monitor the dynamics of SC renewal in live cultures.
Progeny of EOM SCs outperform their LIMB and DIA counterparts in primary culture and clonal analyses -evidence for cell intrinsic distinctions
SCs from LIMB, DIA and EOM muscles (isolated based on Nestin-GFP fluorescence as in Figs. 1B and S3A) were plated at the same density across muscle groups (1000 cells per well in 24-well trays) to follow up the dynamics of cell growth, differentiation and renewal (Fig. 2) . Representative phase images are shown in Fig. 2A-F and overall growth patterns based on the total number of nuclei (DAPI þ nuclei in single cells and myotubes) are illustrated in Fig. 2G . For all three muscle groups, there was little if any growth before the 3rd culture day, followed by a proliferative phase between days 3 and 5, and formation of myotubes that became evident throughout the cultures by day 7 along with continuous cell expansion that was more robust in EOM cultures as clearly discerned by culture days 10 and 14. Growth dynamics were further investigated by double-immunostaining for Pax7 and sarcomeric myosin (MF20) together with DAPI staining (Fig. 2H-K) . While at late time points the percentage of nuclei in differentiated (MF20 þ ) cells among all three muscle groups appeared to be conserved with a value of $ 40% on day 10 and $ 50-60% on day 14 (Fig. 2K ), DIA cultures persistently exhibited an earlier onset of differentiation, already reaching their maximum fusion index by day 7 (Fig. 2K) . The quantification of Nestin-GFP þ /Pax7 þ cells (Fig. 2K) demonstrates a higher presence of renewal cells in EOM cultures. This enhanced renewal could
possibly be related to the overall increased cell density in EOM primary cultures that, based on SC clonal analyses shown next, appears to reflect an intrinsic property of individual EOM SCs. Next, we were interested to determine if the distinct growth and renewal dynamics of EOM primary cultures reflect intrinsic properties of individual SCs. For this, SCs from the three muscle groups, isolated as in Fig. 1B , were analyzed clonally (Fig. 3) . In one set of experiments, clone size was quantified at day 10 based on the total number of DAPI þ nuclei in single cells and myotubes (Fig. 3A-D) . A striking distinction of the EOM clones, evident even before cell counting, was the increased presence of larger and denser clones as illustrated in the lower and higher magnification images ( Fig. 3A and B) . The distribution of clones according to the number of nuclei and cumulative percentile curves are depicted in Fig. 3C . This graph clearly displays greater numbers of clones with higher numbers of nuclei in EOM compared to LIMB and DIA. Only EOM depict clones with more than 12,500 nuclei (6%, 5 out of 89 total clones), while at the low end, LIMB and DIA have respectively 12 (18%) and 11 (11%) clones with less than 200 nuclei, whereas EOM has none. Descriptive statistics of the clonal data are further summarized in a boxplot format (Fig. 3D) , demonstrating a higher median, a higher average and a higher range of "maximum outliers" for EOM clones. Notably, whereas about 50% (44 out of 89 total) of EOM clones display more than 2900 nuclei, only 8% (5 out of 65 total) of LIMB clones and 13% (13 out of 103 total) of DIA clones harbor such cell number. In a second set of clonal experiments, we monitored the extent of renewal cells within clones, based on the re-appearance of Nestin-GFP þ cells (Fig. 3E and F) . Representative images of day 21 clones (Fig. 3E) illustrate the typical presence of a higher number of renewal cells within EOM clones compared to LIMB and DIA clones. Furthermore, the frequency of clones containing renewal cells was strikingly higher in EOM preparations (Fig. 3F) . At 3 weeks, renewal cells were well pronounced in about 80% of the EOM clones while only about 17% of the LIMB clones contained such cells. DIA clones were not quantified here for renewal cells, but values were found to be in the mid-range between LIMB and EOM based on a separate study where LIMB and DIA were compared (unpublished). Note that the appearance and quantity of renewal cells within clones was in accordance with clone size (Fig. 3F) , with both cell density and presence of myotubes within clones being critical for the development of renewal cells. Indeed, previous studies have noted a relationship between density of myogenic cultures and extent of renewal cells (Day et al., 2010; Ono et al., 2010) . We next investigated the in-vivo proliferative status of EOM SCs compared to their LIMB and DIA counterparts. An a priori increased activity of the EOM cells in vivo, could potentially account for their enhanced in-vitro performance. Our pilot histological studies of muscles from adult mice (4-6 month old) injected with BrdU for 3 days (according to Ieronimakis et al., 2010 ) only detected extremely rare proliferating cells when examined with anti-BrdU or anti-Ki67 antibodies, while many nuclei in the periocular glandular tissue were positive (data not shown). This rarity of proliferating cells combined with the paucity of SCs in adult muscles (Fig. S2A-C  0 ) , prompted us to analyze SC proliferative status in freshly isolated cells released from whole muscle, which permits looking at populations large enough for a meaningful comparison between EOM, LIMB and DIA muscles ( Fig. 4A and B) . We opted here to look at unsorted populations, allowing us to gain insight into both the SC population (Pax7 þ cells) and the non-myogenic cells, and to obtain cell numbers high enough for effective cell pelleting by cytocentrifugation (especially important for the EOM with its smaller size and SC numbers). In all three muscle groups from adult mice (4-6 month old), the percentage of proliferating SCs (Ki67 þ /Pax7 þ cells out of total Pax7 þ cells) was low (0.8%, 1.5% and 0.3% for LIMB, DIA and EOM, respectively, Fig. 4B ). Although an earlier study reported that mouse EOMs distinctively retain a pool of activated SCs in adult life (McLoon and Wirtschafter, 2002) , the proliferative index was also relatively low ( $1%) and was expressed as frequency of myofibers harboring BrdU þ SCs in cross sections, while in our current study, values were obtained in reference to total number of Pax7 þ cells. For an additional control, Pax7/Ki67 immunostaining analyses were also performed on cells dissociated from muscles of juvenile mice (3-week old) in which SCs are known to be more proliferative. While LIMB and DIA preparations showed an increase in the frequency of proliferating SCs with younger age, only a minimal change was identified for EOM SCs (Fig. 4B) , suggesting that in-vivo proliferation of EOM SCs ceases earlier in juvenile life. It is conceivable that the smaller diameter of EOM myofibers indeed entails a shorter period of myofiber enlargement by myonuclear accretion. Human studies have shown that EOM myofibers attain maximal diameter by $12 year of age, while limb and body muscles reach their maximal myofiber diameter $ 20 years of age (Grounds and Shavlakadze, 2011) . Myofiber growth by nuclear accretion is known to cease earlier than the subsequent growth by cytoplasmic enlargement; e.g., in the mouse LIMB (EDL muscle) myonuclear addition occurs until 3 weeks of age while growth by volume continues even at 8 weeks of age (White et al., 2010) . Intriguingly, this hypothesis of an earlier cession of EOM SC proliferation during the juvenile growth phase could theoretically be an underlying factor for the increased performance of EOM SCs in the in-vitro analyses summarized above. Collectively, we have demonstrated that adult EOMs harbor Pax7 þ SCs that are quiescent, typical to SCs in prototypic adult muscles, but are uniquely endowed with a high proliferative potential as revealed in cell culture assays. This comprehensive study of SC performance is the first to demonstrate the superiority of EOM SCs not only in primary culture but also at the clonal level, showing a superior growth potential and renewal capacity compared to SCs from "traditional" muscle groups. The superiority of EOM SCs is also maintained in aging according to our primary culture and clonal studies with cells isolated from 22-24 month old mice (Fig. S4A-C) .
EOM SCs from dystrophin-null mdx 4cv mice retain performance superiority As detailed in Introduction, the EOMs are spared in Duchenne muscular dystrophy and in animal models lacking dystrophin. . The prevailing view that SC proliferative potential is exhausted over time in Duchenne muscular dystrophy (due to ongoing demand for SC contribution during the repeated rounds of myofiber degeneration and regeneration, Webster and Blau, 1990) would suggest that EOM SCs are not affected in the dystrophin-null muscle as they are not exposed to ongoing regenerative demand in the in-vivo state. If dystrophin is however required for actual SC performance, once the EOM SCs from dystrophin-null muscles are (D) Clonal data analyzed in (C) are also illustrated as boxplots, depicting the quartile distribution, mean (black crosses) and outliers (red circles, right y-axis) for the number of nuclei per clone; whisker ranges and outliers were calculated as previously detailed by us in . Asterisk denotes statistically significant difference in clone size between EOM vs. LIMB and DIA clones (p o0.01). (E) Representative phase and fluorescence images of day 21 clones established from LIMB, DIA and EOM SCs showing Nestin-GFP þ renewal cells with a typical higher manifestation in EOM clones. (F) Quantification of SC clones that harbor Nestin-GFP þ cells demonstrates that renewal cells are consistently more frequent in EOM clones. The relative clone size was also estimated by categorizing each clone as small, medium, large or X-large depending on whether the clone occupied a 20 Â , 10 Â , 4 Â or several 4 Â objective fields, respectively. On day 7, only EOM cultures displayed clones in the "Large" category. Then, by day 21, solely EOM harbored "X-Large" clones, while clones falling in the two smaller categories represented only 30% of total clones for EOM vs. 60% for LIMB cultures. Scale bars, 1 mm (A), 250 μm (B), 50 μm (E).
prompted to enter a regenerative activity, they may exhibit a declining performance compared to wildtype EOM SCs.
To bypass the distinctive in-vivo milieu of the cells in affected (LIMB and DIA) or unaffected (EOM) environments of dystrophinnull muscles we again compared SCs in culture, using the mdx 4cv mice as the source for dystrophin-null SCs. Fig. 5 depicts images of H&E stained muscle sections from LIMB, DIA and EOM of adult mdx 4cv mice. The series of histological images illustrates that while LIMB and DIA display typical signs of muscle pathology associated with the absence of dystrophin (central myonuclei, split myofibers and fibrosis, with the latter more pronounced in DIA), EOM show no such pathology. Noticeably, the retractor bulbi (RB), an ocular accessory muscle, although residing adjacent to the EOM (Fig. 5E ) and of the same Pax3-negative embryonic origin (Stuelsatz et al., 2014) , is affected by dystrophin absence as demonstrated by the extensive presence of central myonuclei similar to LIMB (Fig. 5A) . EOM sparing vs. RB pathology is in accord with earlier findings in the "standard" mdx mouse (Andrade et al., 2000; Marques et al., 2007) .
To enable sorting of SCs from mdx 4cv muscles, we generated a colony of mdx 4cv /Nestin-GFP mice. We first confirmed that the agreement between Pax7 and Nestin-GFP was retained in the dystrophin-null mouse (Fig. S5A-D″) . In this set of experiments, the inclusion of antigen-based sorting (Fig. S3B ) has enabled us to assay the frequency of CD45 þ hematopoietic cells (Fischer et al., 1991) , which are involved in inflammatory and fibrosis processes that occur in mdx pathology (Fischer et al., 1991; Morrison et al., 2000; Spencer et al., 2001; Villalta et al., 2009 (Fig. 6 ): (i) In accordance with the muscle histopathology evidence (Fig. 5) , the frequency of CD45 þ cells (out of G0-G1 cells) increased significantly (po 0.03) in mdx 4cv LIMB and DIA (Fig. 6D) . In mdx 4cv EOM preparations, there was only a trend (but not a statistical difference, p ¼0.06) of CD45 þ cell increase that could likely be explained by the overall increase in inflammatory cell production shown for mdx mice (Lagrota-Candido et al., 2002) . Conversely, there was a decline in SC frequency in LIMB and DIA (p o0.03) isolated preparations from mdx 4cv mice, while EOM preparations were unaffected (p¼ 0.09) when examining sorted populations (Fig. 6D). (ii) Primary cultures from LIMB and DIA of mdx 4cv mice demonstrated only a meager growth (and no appearance of Nestin-GFP þ renewal cells), while mdx 4cv EOM cultures retained robust growth and renewal ( Fig. 6A and B) . In our additional studies of LIMB cultures from juvenile mdx 4cv mice, SC growth impairment was first observed after 6 weeks of age, while cultures appeared normal beforehand. (iii) Clonal assays of SCs further 48.1% out of 7998 and 18.0% out of 4324 total nuclei, in juvenile and adult mice, respectively); these cells were also found negative for Pax7. Scale bar, 50 μm. demonstrated the inability of individual SCs from mdx 4cv LIMB and DIA preparations to establish clones (according to clone number and size), while EOM clones retained robust growth when prepared from mdx 4cv mice ( Fig. 6C and D) . Noticeably, a severely compromised myogenic growth was also observed in isolated EDL myofibers and in cultures of unsorted cell preparations from LIMB vs. APC for anti-CD31 and anti-Sca1) when gating out the CD31 þ , CD45 þ , and Sca1 þ cells. For all panels, asterisks denote statistically significant differences (po 0.03).
and DIA muscles of adult mdx 4cv mice (data not shown), which argues against the possible presence of better performing myogenic progenitors that could have been excluded from our mdx 4cv cell culture assays summarized in Fig. 6 . The impairment of LIMB and DIA SCs from adult mdx 4cv mice that we have persistently observed in cell culture assays seems to be in contrast with the in-vivo regenerative activity observed in affected mdx muscles and presumed to reflect the presence of performing SCs McGeachie et al., 1993; Yokota et al., 2006) . One possible explanation to this discrepancy could be that the residual SC activity detected in the current LIMB and DIA cell cultures from the dystrophindeficient mice is sufficient for supporting the reported in-vivo mdx regenerative activity. Moreover, our unpublished observation that the extent of attrition in primary cell cultures from LIMB and DIA of mdx 4cv mice was somewhat alleviated when initiating cultures at a much higher density further supports the possibility of a beneficial "community effect". Notably, a recent study of mdx mice corroborates our cell culture results with mdx 4cv mice, pointing out to a decline in satellite cell activity in older dystrophin-null mice compared to wildtype (Jiang et al., 2014) . It remains however possible that limb and body muscles are more affected in the mdx 4cv model, as this strain has a lower number of revertants (dystrophin þ ) myofibers than the "standard" mdx mice (Danko et al., 1992) . Indeed, while we observed extensive abnormal morphologies (branching, internal splitting, bifurcation) in most EDL myofibers by 12-16 weeks of age in mdx 4cv mice ( Fig. S5E-H ; see also Banks et al., 2014 for similar conclusions), such level of malformations was observed in "standard" mdx mice only when reaching 26 weeks of age, while less than 5% of the myofibers displayed abnormalities by 15 weeks of age (Head et al., 1992; Williams, 1993) . However, a side by side comparison between mdx 4cv , mdx and wildtype mice, looking at SC clonal growth, myofiber abnormalities and whole muscle regenerative capacity is yet to be performed. Overall, our cell culture experiments where SCs are "freed" from their in-vivo dystrophic context have permitted comparison of SC populations in a common "growth promoting" environment. Using this in-vitro approach, and especially analyzing clonal growth of single cells, we have clearly demonstrated that SCs from LIMB and DIA muscles perform poorly when isolated from dystrophin-null mice, whereas SCs isolated from mdx 4cv EOM were unaffected and performed at the same level as their wildtype counterparts. This comparable (and robust) performance of EOM SCs from mdx 4cv and wildtype mice further indicates that dystrophin is not essential for EOM SC activity, while the poor performance of mdx 4cv LIMB and DIA SCs could possibly be associated with the accelerated myogenic differentiation observed previously in primary cultures from "standard" mdx mice (Yablonka-Reuveni and Anderson, 2006) . Future studies are needed to establish the mechanism behind the preserved or impaired performance of SCs from the different muscle groups of dystrophin-null mice.
EOM SCs demonstrate higher engraftment efficiency after intramuscular transplantation
In the studies described above we evaluated SC performance in cell culture, thereby providing an identical environment in which to study all SCs populations from wildtype and mdx 4cv mice for LIMB, DIA and EOM. The goal of this engraftment study was to evaluate whether the regenerative superiority of EOM SCs revealed in cell culture assays is maintained in vivo when SCs are again exposed to a common environment. For this, donor SCs from EOM and LIMB were transplanted into tibialis anterior (TA) muscles of Rag1 À / À /mdx 5cv mice. The dystrophin-null context has provided a muscle environment that promotes SC myonuclear contribution due to ongoing muscle repair, while the Rag1-null context minimizes possible rejection of donor cells as the mutant lacks mature B and T cells (see Materials and methods). Given the distinct lineage origin of donor EOM SCs and host TA muscles, we first validated that EOM and LIMB SC progeny could fuse with each other. Using a co-culture approach with reporter-specific marking per each lineage, we demonstrated that progeny of EOM SCs frequently generated hybrid myotubes with their LIMB counterparts (Fig. S6) . For the engraftment study, donor SCs were isolated by flow cytometry based on Nestin-GFP expression (Figs. 1B and S3A ) from Nestin-GFP/MLC3F-nLacZ double transgenic mice. As detailed in Materials and methods, the muscle-specific MLC3F-nLacZ transgene drives β-gal expression in myofiber nuclei, providing a histological means to trace contribution of differentiated progeny of donor SCs based on X-gal staining. Additionally, both Nestin-GFP and MLC3F-nLacZ transgenes were used here to quantify donor contribution based on a genomic analysis (PCR on isolated gDNA). To minimize engraftment variations due to potential mouse to mouse differences, comparisons between EOM and LIMB donor SCs were done within individual host mice, with EOM SCs being injected into one TA muscle and LIMB SCs into the contralateral TA muscle. For each independent experiment (n ¼ 4), 3-4 host mice were engrafted with EOM and LIMB SCs populations isolated from the same cohort of donor mice. Injected TAs were harvested 3 weeks after transplantation and for each experiment 1-2 mice were processed for X-gal staining and the rest for genomic analysis.
Inspection of X-gal staining in whole TAs demonstrated that donor EOM SCs contributed nLacZ þ myonuclei at a greater level than LIMB SCs (Fig. 7B) . The detection of the nuclear reporter nLacZ in myonuclei upon donor cell engraftment is not necessarily an exact reflection of the number of donor-derived nuclei as the reporter protein, translated in the myofiber cytoplasm, may also enter host myonuclei within neighboring domains of the same myofiber (Kirillova et al., 2007; Yang et al., 1997) . However, the degree of MLC3F-nLacZ nuclei in donor muscle is certainly related to the degree of engraftment and provides an efficient qualitative measure. Donor cell contribution was further quantified by genomic analysis according to the donor-specific LacZ and GFP levels each normalized to the level of two reference genes (Cyp1A1 and H-ras), which permitted calculating the ratio between EOM and LIMB engraftment per individual mice as detailed in Fig. 7C and D.
The majority of mice analyzed demonstrated a higher engraftment of EOM SCs with EOM/LIMB engraftment ratios at $ 1.8-5.6 (n ¼ 7), while no mice harbored a significant higher engraftment of LIMB SCs. A pilot engraftment analysis of EOM vs. DIA SCs performed as above also indicated a better efficiency of EOM SCs. This genomic analysis detects donor contribution, regardless of whether cells contributed to myofiber nuclei or just engrafted into the muscle tissue. Hence, the use of both the histological and PCR approaches has provided a more comprehensive insight into the engraftment potential of each SC population, demonstrating altogether the regenerative superiority of EOM SCs in terms of in-vivo engraftment potency.
Concluding remarks
Our findings contribute novel insights into EOM SCs, focusing on their in-situ signature, in-vitro expansion, and in-vivo engraftment aptitude. To identify potential unique properties of EOM SCs, most aspects were analyzed in comparison to SCs from the limb and diaphragm muscles. We have shown that EOM SCs, regardless of their distinctive Pax3-negative origin, display a common in-situ molecular signature with their limb and diaphragm counterparts (Pax7 þ , Ki67 À , Nestin-GFP þ , Myf5 nLacZ þ , MyoD-positive lineage origin). Further comparisons among the three muscle groups have demonstrated that EOM SCs possess a superior expansion capacity, contributing significantly more proliferating and differentiating progeny and impressively, many more renewal cells than their limb and diaphragm counterparts. Interestingly, SCs of the masseter muscle were also shown to have a larger proliferative and renewal potential when compared clonally with EDL SCs (Ono et al., 2010) . The masseter is also of a Pax3-negative origin, but is classified within a muscle group distinct from the EOMs (Harel et al., 2009) . While the masseter progenitors are derived from an Isl1-positive lineage (and also show ancestral expression of Nkk2.5), the EOM progenitors are not (Harel et al., 2009 ). Although it is tempting to consider the Pax3-negative origin of SCs in both EOM and masseter as playing a role in the expanded performance capacity of SCs from these muscles, a side by side comparison of SCs from these two lineages is first required. Additionally, we showed that the robust growth and renewal properties of EOM SCs are maintained in preparations isolated from dystrophin-null (mdx 4cv ) mice, while SCs from muscles affected by dystrophin deficiency (i.e., limb and diaphragm) expand poorly in cell culture assays. EOM SCs also retain higher performance in cell transplantation assays in which donor cells were engrafted into host mdx limb muscle.
Collectively, our study provides a comprehensive picture of EOM myogenic progenitors, showing that while these cells share common hallmarks with the prototypic SCs in somite-derived muscles, they distinctively feature robust growth and renewal capacities that warrant the title of high performance myo-engines and promote consideration of their properties for developing new approaches in cell-based therapy to combat skeletal muscle wasting. Insights into the specific traits that underlie the EOM SCs' robust performance can potentially establish new molecular avenues for manipulating donor myogenic progenitors from the easily accessible limb muscles. Furthermore, if proven relevant for clinical use (i.e., expandable in vitro with resulting progeny retaining high regenerative potency in vivo), human EOM SCs could serve directly as an effective source for cell-based therapy. Indeed, a protocol for retrieving human EOMs could ultimately be developed based on the already existing Eye Bank programs, allowing for the availability of a wide range of allotypes of human donor EOM cells.
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